Cargando…

Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations

Assessing the duration of neutralizing antibodies (nAbs) following SARS-CoV-2 infection or vaccination is critical to evaluate the protective immunity and formulate public health strategies. In this study, SARS-CoV-2 Ab ELISA (enzyme-linked immunosorbent assay), chemiluminescent microparticle immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Caiqin, Li, Dan, Liu, Zhanmou, Ren, Li, Su, Junwei, Zhu, Meiling, Feng, Yi, Wang, Zheng, Liu, Qiang, Zhu, Biao, Shao, Yiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878712/ https://www.ncbi.nlm.nih.gov/pubmed/35215115 http://dx.doi.org/10.3390/pathogens11020171

Ejemplares similares

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents
por: Wang, Zheng, et al.
Publicado: (2023)

Neutralizing antibodies in convalescent patients
por: Uhl, Lion F. K., et al.
Publicado: (2020)

Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID‐19 cohorts by chemiluminescent immunoassays
por: Dou, Xiaowen, et al.
Publicado: (2022)

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
por: Muecksch, Frauke, et al.
Publicado: (2020)

Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum
por: Liang, Dan, et al.
Publicado: (2022)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan
por: Huang, Yen-Fang, et al.
Publicado: (2023)

Changes in Serum Neutralizing Antibodies Levels During Convalescence of COVID-19 Patients
por: Chen, Qing-Qing, et al.
Publicado: (2022)

Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
por: Chen, Ying, et al.
Publicado: (2023)

A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)

Longitudinal analysis of antibody decay in convalescent COVID-19 patients
por: Xia, Weiming, et al.
Publicado: (2021)

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
por: Cao, Yunlong, et al.
Publicado: (2022)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
por: Dulipsingh, Latha, et al.
Publicado: (2023)

Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients
por: Chen, Jun, et al.
Publicado: (2023)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021)

Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents
por: Zheng, Yufen, et al.
Publicado: (2023)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
por: Jazbec, Katerina, et al.
Publicado: (2023)

Identification of a novel broadly HIV-1-neutralizing antibody from a CRF01_AE-infected Chinese donor
por: Ju, Bin, et al.
Publicado: (2018)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
por: Mu, Song, et al.
Publicado: (2022)

Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
por: McConnell, Scott A., et al.
Publicado: (2023)

Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
por: Sullivan, David J, et al.
Publicado: (2022)

Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
por: Xiang, Tiandan, et al.
Publicado: (2021)

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
por: Zhou, Yunjiao, et al.
Publicado: (2021)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects
por: Manenti, Alessandro, et al.
Publicado: (2022)

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
por: Kaku, Yu, et al.
Publicado: (2021)

Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patients
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2021)

Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
por: Bäuerl, Christine, et al.
Publicado: (2023)

Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries
por: Pan, Yongbing, et al.
Publicado: (2021)

Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection
por: Yan, Li-Na, et al.
Publicado: (2022)

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
por: Cao, Yunlong, et al.
Publicado: (2020)

Detection and analysis of variants of JC polyomavirus in urine samples from HIV-1-infected patients in China’s Zhejiang Province
por: Hu, Caiqin, et al.
Publicado: (2018)

High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
por: Li, Maggie, et al.
Publicado: (2022)

Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies
por: Sun, Ming, et al.
Publicado: (2016)

A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3
por: Chen, Pan, et al.
Publicado: (2016)

Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection
por: Valiant, William G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pkg4lk6te7utsjaci5k64q51tm